诺诚健华(09969.HK)拟11月14日举行2025年第三季度业绩说明会

Core Viewpoint - The company, Innovent Biologics (09969.HK), announced that it will release its Q3 2025 financial report on November 14, 2025, and will hold a performance briefing to discuss the results and address investor concerns [1] Group 1 - The company plans to hold a performance briefing on November 14, 2025, from 11:00 AM to 12:00 PM [1] - The briefing aims to provide investors with a comprehensive understanding of the company's Q3 2025 operational results and financial status [1] - The event will facilitate communication regarding issues of interest to investors [1]